Eligibility criteria for prophylactic treatment allowance

Similar documents
Advice about familial aspects of breast cancer and epithelial ovarian cancer

GENETIC MANAGEMENT OF A FAMILY HISTORY OF BREAST AND / OR OVARIAN CANCER. Dr Abhijit Dixit. Family Health Clinical Genetics

Breast Cancer Screening Clinical Practice Guideline. Kaiser Permanente National Breast Cancer Screening Guideline Development Team

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

Risk Assessment and Risk Management

Genetic Testing for BRCA1 and BRCA2 Genes

Utilization of BRCA Testing. Breast and Ovarian Cancer in Texas

BRCA Precertification Information Request Form

Genetic Screening Visit

Genetic Testing for BRCA1 and BRCA2 Genes

So how much of breast and ovarian cancer is hereditary? A). 5 to 10 percent. B). 20 to 30 percent. C). 50 percent. Or D). 65 to 70 percent.

Policy and Procedure. Department: Utilization Management. SNP, CHP, MetroPlus Gold, Goldcare I&II, Market Plus, Essential, HARP

Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening. Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 15, 1997 October 9, 2013

Clinical guideline Published: 25 June 2013 nice.org.uk/guidance/cg164

Policy #: 259 Latest Review Date: November 2009

Genetic Testing for Lynch Syndrome

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

Prior Authorization. Additional Information:

Corporate Medical Policy Genetic Testing for Breast and Ovarian Cancer

Primary Care Approach to Genetic Cancer Syndromes

So, Who are the appropriate individuals that should consider genetic counseling and genetic testing?

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

MANAGEMENT OF HIGH RISK BREAST PATIENTS DR PAMELA THOMPSON BREAST PHYSICIAN, FSH

This information explains the advice about familial breast cancer (breast cancer in the family) that is set out in NICE guideline CG164.

Sporadic Cancer - Cancer which occurs by chance. People with sporadic cancer typically do not have relatives with the same type of cancer.

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.

Importance of Family History in Gynecologic Cancer Prevention. Objectives. Genetic Counselors. Angela Thompson, MS, CGC

CANCER GENETICS PROVIDER SURVEY

Applies to: All Aetna plans, except Traditional Choice plans. All Innovation Health plans, except indemnity plans

Prophylactic Mastectomy

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

patient education Fact Sheet

Does Cancer Run in Your Family?

FAQ-Protocol 3. BRCA mutation carrier guidelines Frequently asked questions

Cancer Genomics 101. BCCCP 2015 Annual Meeting

Genetic Risk Evaluation and Testing Program

Precision Medicine and Genetic Counseling : Is Yes always the correct answer?

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

POSITIVE DELETERIOUS MUTATION

Breast Cancer Prevention Studies. Key Points. Breast cancer prevention studies are clinical trials (research studies conducted with

PATIENT INFORMATION. (Last) (First) (Middle) (Last) (City) (State) (Zip)

Hereditary Cancer Products

Clinical options for mutations of BRCA 1/2 genes. Ioannis Th. Natsiopoulos Breast surgeon

Prophylactic Mastectomy

Myriad Financial Assistance Program (MFAP)

WHAT DO GENES HAVE TO DO WITH IT? Breast Cancer Risk Assessment and Risk Reduction in 2016

FACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer?

Management of BRCA Positive Breast Cancer. Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH

Lori Carpenter, MS, LCGC Saint Francis Hospital

Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document.

Inherited Ovarian Cancer Diagnosis and Prevention

For identification, support and follow up related to Familial Gastrointestinal Cancer conditions. South Island Cancer Nurses Network September 2013

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

A Patient s Guide to. Hereditary Ovarian Cancer: Is Hereditary Cancer Testing Right for You?

Page 1 of 8 TABLE OF CONTENTS

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing.

BRCAplus. genetic testing for hereditary breast cancer

PROVIDER POLICIES & PROCEDURES

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18

GENETIC TESTING FOR HEREDITARY CANCER


Dr Marion Harris (Medical Oncologist)

Genetic Risk Assessment for Cancer

Ovarian Cancer Causes, Risk Factors, and Prevention

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR HEREDITARY BRCA MUTATIONS. POLICY NUMBER: CATEGORY: Laboratory Test

MP Genetic Testing for BRCA1 or BRCA2 for Hereditary Breast/Ovarian Cancer Syndrome and Other High-Risk Cancers

Health technology Prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.

BRCAnowTM It s Your Decision

Predictive and Diagnostic Testing for Cancer in Women. Aparna Rajadhyaksha MD

Coversheet for Network Site Specific Group Agreed Documentation

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

Identification of patients suggestive of hereditary breast and ovarian cancer syndrome that warrants further professional evaluation.

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

Contralateral Prophylactic Mastectomy with Immediate Reconstruction: Added Benefits, Added Risks

Genetic Determinants, Risk Assessment and Management

Clinical Genetics Service

PMS2 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) PMS2 Summary Cancer Risk Table

Genetic Risk Assessment for Cancer

MSH6 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) MSH6 Summary Cancer Risk Table

Hereditary Cancer Risk Assessment for Gynecological Cancers. FarrNezhatMD.com

Content. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

Hereditary Cancer Update: What do GPOs need to know?

Breast Cancer Screening and Treatment Mrs Belinda Scott Breast Surgeon Breast Associates Auckland

Cigna Medical Coverage Policy

Screening for Genes for Hereditary Breast and Ovarian Cancer in Jewish Women

Breast Cancer. Dr. Andres Wiernik 2017

HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond.

Genetic/Familial High-Risk Assessment: Breast and Ovarian

Health Authority Abu Dhabi

Understanding Your Positive Result. A guide to understanding your risk and taking action

Prophylactic Mastectomy

Reference #: SYS-PC-VPCI-CG-002. Origination Date: June 2012 Next Review Date: April 2019 Effective Date: April 2016

WELCOME. Taking Care of Your Health. April 30, 8 am to noon

Patient Information. Name: (Last) (First) (Middle) Address: (Street) (City) (State) (Zip) Home Phone: Cell Phone: address:

Information for You and Your Family

Transcription:

Eligibility criteria for prophylactic treatment allowance Southern Cross will only pay the prophylactic treatment allowance for the following healthcare services when the applicable eligibility criteria are met for that member: IMPORTANT: If the high risk status was present prior to the member joining Southern Cross (the original date of joining or ODJ), then the member will not be eligible for the prophylactic treatment allowance relating to this risk unless the member has cover for their pre-existing conditions. If the member was aware of a gene mutation at the time they joined Southern Cross then this is considered a pre-existing condition and will be excluded from cover under this allowance (unless the member has cover for their pre-existing conditions). 1. Eligibility criteria for prophylactic mastectomy and reconstruction Southern Cross will approve payment for the eligible healthcare service if the member is considered potentially high risk by meeting one of criteria A, or B, or C below. A. Family History Category Three Potentially High Risk (based on the National Breast and Ovarian Cancer Centre (NBOCC) publication on familial aspects of cancer (December 2010)). Member has had two first-degree or second- degree relatives on one side of the family diagnosed with breast or ovarian cancer, plus one or more of the following has occurred on the same side of the family: o additional relative(s) with breast or ovarian cancer o breast cancer was diagnosed in one of the relatives before the age of 40 o one of the relatives was diagnosed with bilateral breast cancer o one of the relatives had breast and ovarian cancer diagnosed o Jewish ancestry o breast cancer has been diagnosed in a male relative. Member has had one first-degree or second-degree relative diagnosed with breast cancer at age 45 or younger, plus another first-degree or seconddegree relative on the same side of the family diagnosed with sarcoma (bone/soft tissue) at age 45 or younger. The member meets the potentially high risk criteria of ovarian cancer (see below for eligibility criteria for prophylactic bilateral salpingo-oophorectomy). Note We allow the member to count as one of the relatives in the above criteria for potentially high risk family history. In other words, if the member has had previous breast cancer this would be considered as one first-degree family member with breast cancer.

B. If the member has lobular carcinoma in situ or invasive lobular carcinoma in a cancer affected breast (a histology report is required to confirm this), the contralateral breast will be considered at high risk. C. If the member has BRCA 1 or BRCA 2 gene mutation they are considered high risk (requires confirmation by genetic study report).

2. Eligibility criteria for prophylactic bilateral salpingo-oophorectomy Southern Cross will approve payment for the eligible healthcare service if the member is considered potentially high risk by meeting at least one of the criteria listed under A below: A. Family History Category Three Potentially High Risk (based on the National Breast and Ovarian Cancer Centre (NBOCC) publication on familial aspects of cancer (December 2010)). The member is at high risk of breast cancer due to a gene fault; e.g. the presence of BRCA 1 or BRCA 2 gene (requires confirmation by genetic study report). The member has had one first-degree or second-degree relative diagnosed with epithelial ovarian cancer in a family of Ashkenazi Jewish ancestry. The member has had one first-degree or second-degree relative diagnosed with ovarian cancer at any age and another with breast cancer before the age of 50, where those women are first-degree or second-degree relatives of each other. The member has had two first-degree or second-degree relatives on the same side of the family diagnosed with epithelial ovarian cancer, where one or more of the following has occurred on the same side of the family: o additional relative(s) with breast or ovarian cancer o breast cancer in one of the relatives was diagnosed before the age of 40 o one of the relatives was diagnosed with bilateral breast cancer o one of the relatives had breast and ovarian cancer diagnosed o breast cancer has been diagnosed in a male relative. The member has had three or more first-degree or second-degree relatives on the same side of the family diagnosed with a family history suggestive of Lynch Syndrome (or HNPCC), e.g. colorectal cancer (particularly if diagnosed before the age of 50), endometrial cancer, ovarian cancer, gastric cancer, and cancers involving the renal tract.

3. Eligibility criteria for other prophylactic treatment If a member requires prophylactic treatment other than the healthcare services covered under points 1 and 2 above, a genetics report confirming a geneticist s support for prophylactic treatment is required. Eligibility for cover will be at Southern Cross discretion.

Notes and conditions Prophylactic healthcare services means healthcare service(s) provided in the absence of any relevant sign or symptom suggesting the presence of an illness, disease or medical condition, that seek to reduce or prevent the risk of an illness, disease or medical condition developing in the future. The prophylactic treatment allowance is to cover the costs of prophylactic treatment to address a highly increased risk of developing a disease. All terms and conditions of the policy must be met in order for a member to be entitled to cover under this allowance. Definition of family relationships First-degree relatives: parents, siblings and children Second-degree relatives: aunts, uncles, nieces, nephews, grandparents.